Drug intelligence / Profile preview

ursodeoxycholic acid + Qingre Lidan Pian

Development stage
Unknown
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

This is a combination drug consisting of ursodeoxycholic acid (UDCA), a synthetic bile acid, and Qingre Lidan Pian, a traditional Chinese medicine formulation. Ursodeoxycholic acid increases bile flow, reduces cholesterol saturation in bile, and dissolves cholesterol gallstones. It also has immunomodulatory and cytoprotective effects on hepatocytes. Qingre Lidan Pian typically contains herbal ingredients such as rhubarb (Da Huang), capillaris (Yin Chen), and lysimachia (Jin Qian Cao) that promote bile secretion, clear heat, reduce inflammation, relieve pain, and facilitate the expulsion of small stones from the biliary tract. The combination is primarily used for treating cholesterol-type gallstones, cholecystitis (gallbladder inflammation), cholestatic liver diseases such as primary biliary cholangitis or chronic hepatitis with intrahepatic cholestasis, prevention of drug-induced calculi formation, steatorrhea after ileal resection surgery, and to support overall liver-biliary health[3][5][7].

Other names
熊去氧胆酸+清热利胆片
02

Targets

IL-6 (Interleukin 6)ABCB11 (Bile salt export pump)

Beyond the preview

Go deeper on ursodeoxycholic acid + Qingre Lidan Pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ursodeoxycholic acid + Qingre Lidan Pian.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call